The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia
Crossref DOI link: https://doi.org/10.1007/s11899-016-0335-0
Published Online: 2016-08-06
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
BirgegÄrd, Gunnar
Funding for this research was provided by:
Uppsala University
License valid from 2016-08-06